- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 261/16 - Benzene-sulfonamido isoxazoles
Patent holdings for IPC class C07D 261/16
Total number of patents in this class: 66
10-year publication summary
|
6
|
8
|
6
|
8
|
3
|
4
|
6
|
0
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Xenon Pharmaceuticals Inc. | 197 |
7 |
| Dompé Farmaceutici S.p.A. | 299 |
3 |
| Eastern Virginia Medical School | 64 |
3 |
| The Regents of the University of California, Santa Cruz | 17 |
3 |
| Thomas Jefferson University | 554 |
3 |
| Biofront Ltd. (Cayman) | 17 |
3 |
| Elara Pharmaceuticals GmbH | 9 |
2 |
| European Molecular Biology Laboratory (embl) | 22 |
2 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 377 |
2 |
| Sanford-Burnham Medical Research Institute | 125 |
2 |
| Theaprin Pharmaceuticals Inc. | 32 |
2 |
| Shanghai Hansoh Biomedical Co., Ltd. | 356 |
2 |
| Nissan Chemical Corporation | 2227 |
2 |
| The Royal Institution for The Advancement of Learning / McGill University | 713 |
2 |
| The United States of America Department of Health | 2 |
2 |
| Novartis Pharma AG | 227 |
1 |
| Boehringer Ingelheim International GmbH | 4493 |
1 |
| Centre National de La Recherche Scientifique | 11023 |
1 |
| Vertex Pharmaceuticals Incorporated | 1582 |
1 |
| Curegenix, Inc. | 15 |
1 |
| Other owners | 21 |